Literature DB >> 25960645

Helicobacter pylori infection in Chinese patients with atrial fibrillation.

De-Zhao Wang1, Wei Chen1, Song Yang2, Jun Wang3, Qun Li1, Qiang Fu2, Shi-Jing Li3, Bu-Xing Chen1.   

Abstract

OBJECTIVE: To explore the relationship between Helicobacter pylori (Hp) infection and atrial fibrillation (AF) in Chinese patients.
METHODS: A total of 285 hospitalized patients with AF and 300 patients from Health Screening Center who matched age and sex with AF group were enrolled. AF patients were divided into two groups: the short-standing AF category (less than a year) and the long-standing AF category (more than a year). All patients had laboratory testing of (13)C urea breath test, high-sensitive C-reactive protein (hs-CRP) and left atrial diameter (LAD). We analyzed the difference of these factors in all groups and explored the correlation between Hp infection and AF using logistic regression analysis.
RESULTS: Both AF groups had more hypertension, diabetes, and Hp infection than the control group. The Hp value and the hs-CRP level in patients with long-standing AF were higher than those in the short-standing AF and the control groups (for Hp value: P<0.001 for both and for hs-CRP level: P=0.003, 0.002, respectively). The LAD of patients in the long-standing AF group was significantly larger than those in the short-standing AF group and control group (P=0.001 and P<0.001, respectively). The values of Hp, hs-CRP, and LAD in the long-standing AF category were significantly higher than those in the short-standing AF category (all P<0.05). After controlling the potential confounders, Hp value ≥4‰, hs-CRP >5 mg/L, and LAD >36 mm were significantly related to long-standing AF.
CONCLUSION: The values of Hp in patients with long-standing AF were significantly higher than those in short-standing AF and control groups. Hp δ value ≥4‰ is an independent predictor for long-standing AF.

Entities:  

Keywords:  13C urea breath test; high sensitivity C-reactive protein; left atrial diameter

Mesh:

Substances:

Year:  2015        PMID: 25960645      PMCID: PMC4423503          DOI: 10.2147/CIA.S72724

Source DB:  PubMed          Journal:  Clin Interv Aging        ISSN: 1176-9092            Impact factor:   4.458


Introduction

Atrial fibrillation (AF) is one of the most common clinical arrhythmias and easily complicated by cardiac insufficiency and thromboembolic complications, which seriously affect the patients’ quality of life. The occurrence and maintenance mechanism of AF is not very clear at present. Some studies reported that the structural and electrophysiological basis of the occurrence of AF might be the left atrial reentrant micro ring and enlarged left atrium.1 Some researchers found that elevated plasma high-sensitive C-reactive protein (hs-CRP) level was an independent risk factor for AF, which indicated that chronic inflammation seemed to play an important role in the development of AF.2 A study from the digestion department of internal medicine (Beijing Mentougou District Hospital, Beijing China) showed that the Helicobacter pylori (Hp) infection rate was as high as 50% in Chinese adults, and Hp was not only an important pathogenic reason for chronic gastritis and stomach cancer but also closely related to the occurrence of non-gastrointestinal diseases.3 Some studies showed that chronic Hp infection was involved in AF and it played an important role in the development of AF,4–8 but others demonstrated that Hp infection was not correlated with AF.9–11 However, these studies had relatively small sample sizes, and none of the patients have been classified into different AF-type categories in accordance with the guidelines to further explore the correlation between Hp infection and different types of AF. The purpose of this study was to clarify the relationship between Hp infection and the different types of AF, and to investigate the occurrence and maintenance mechanism of AF.

Materials and methods

Subjects

This study consisted of a retrospective analysis of a single-site cohort. The consecutive hospitalized patients with AF (excluding cardiac insufficiency, acute coronary syndrome, thyroid dysfunction, and any infections) in Beijing Tiantan Hospital from January 1, 2007 to April 12, 2013 were selected. The control group came from Health Screening Center during the same period, and their age and sex matched those of the AF group. Subjects who had suffered gastrointestinal bleeding within 1 week; had a history of gastrectomy; used antibiotics, bismuth, or sucralfate within 1 month; had a chronic infection; had obesity; had heart failure; or had other conditions that might increase IL-6 promoting chronic inflammatory response were excluded. There were 110 males (38.6%) and 175 females (61.4%). Patient history, physical examination, and laboratory results were recorded with chart abstraction. Their average age was 63.8±10.8 years. Patients were divided into two groups: the short-standing AF group, in whom the symptoms persisted for less than 1 year, and the long-standing AF group, in whom the symptoms persisted for more than 1 year.

Tests and examinations

Routine examination

All the patients underwent the following tests/examinations on the next day after admission: blood routine, biochemical items, glycosylated hemoglobin, hs-CRP, homocysteine (HCY), 13C urea breath, blood coagulation, and ultrasonic cardiogram (UCG).

13C urea breath test

The 13C urea breath test was measured using the HCBT-01 breath test automatic instrument (Shenzhen Zhonghe Haidewei Biological Technology Co. Ltd), and the determination whether patients had Hp infection was calculated by 13C/12C isotope ratio (δ ‰). Subjects were asked to fast more than 2 hours before blood tests. The positive value of Hp infection was defined as δ≥4‰±0.4‰.

Hs-CRP and Hp antibody level

Hs-CRP was measured using particle-enhanced immune transmission turbidimetry (DiaSys Diagnostic Systems of GmbH). Hp-IgG antibody was measured by the colloidal gold method (Shanghai Enterasys Biological Technology Co. Ltd).

UCG examination

UCG examination was performed using the United States GE Vivid 7 ultrasound heartbeat graph diagnosis system. Patients were asked to be in the left lateral position. The parasternal long axis, parasternal short axis, apical four-chamber view, and apical two-chamber view were used. Left ventricular end-diastolic diameter and left atrial diameter (LAD) were measured by using the parasternal long axis view. Biplane Simpson formula was used to quantify left ventricular ejection fraction.

Statistical methods

Baseline characteristics of patients were compared using ANOVA for continuous variables and the chi-squared test for non-continuous variables. When continuous data were not normally distributed, groups were compared using nonparametric Wilcoxon rank sum test. The correlation between baseline characteristics and long-standing AF was tested using a univariate logistic regression model. Clinically significant variables were entered into a multivariate regression model. P<0.05 was statistically significant. Statistical analysis was performed using the SPSS software (version 13.0).

Results

The baseline data of each group

Control group had 300 (51.3%) patients, short-standing AF group had 126 (21.5%) patients, and long-standing AF group had 159 (27.2%) patients. The baseline data of each group are shown in Table 1. There were significant differences in age, heart rate (HR), neutrophils (NEU), LAD, hs-CRP, and HCY among the groups. Patients with long-standing AF were older and had a higher value of HR, NEU, LAD, hs-CRP, and HCY than those with short-standing AF (Table 1).
Table 1

The baseline data of each group

GroupControl group (n=300)AF group
P-value
Short-standing AF group (n=126)Long-standing AF group (n=159)P-value
Female, n198 (66.0%)82 (65.1%)93 (58.5%)0.2560.265
Smoke, n159 (53.0%)66 (52.4%)81 (50.9%)0.8090.916
Alcohol, n89 (29.7%)43 (34.1%)54 (34.0%)0.9770.525
Hypertension, n221 (73.7%)99 (78.6%)121 (76.1%)0.6220.546
Dyslipidemia, n112 (37.3%)55 (43.7%)62 (39.0%)0.4270.475
Diabetes mellitus, n90 (30.0%)32 (25.4%)54 (34.0%)0.1180.293
Cerebral infarction, n82 (27.3%)37 (29.4%)54 (34%)0.4080.334
Hematencephalon, n7 (1.2%)5 (0.9%)4 (0.7%)0.4860.628
Family history of AF, n11 (3.7%)7 (5.6%)5 (3.1%)0.3140.550
Arteriosclerosis, n190 (63.3%)85 (67.5%)116 (73.0%)0.3120.113
Fundus abnormal, n268 (89.3%)112 (88.9%)135 (84.9%)0.4620.205
Mean age ± SD (years)60.2±10.6562.1±11.7865.1±9.800.022<0.001
Mean SBP ± SD (mmHg)135±22.3132±23.1136±22.30.2350.478
Mean heart rate/minute74±12.376±16.079±14.50.019<0.001
Mean WBC ± SD (109/L)7.3±2.307.4±2.507.4±2.530.8510.919
Mean NEU ± SD (109/L)4.9±1.445.3±1.606.3±2.19<0.001<0.001
Mean LVEF ± SD (%)61.4±10.1361.9±10.8060.8±10.550.3630.654
Mean LAD ± SD (mm)32.9±4.4534.8±4.7936.7±5.860.001<0.001
Mean BMI ± SD (kg/m2)25.5±3.8825.2±3.4125.4±4.160.6730.681
Median hs-CRP (mg/L) (interquartile range)8.00 (5.34–12.00)8.00 (4.87–13.29)12.60 (7.60–24.00)0.0020.003
Median HCY (μmol/L) (interquartile range)9.90 (4.57–16.10)11.90 (9.76–17.20)12.60 (10.12–20.10)0.005<0.001
Hp-IgG antibody131 (43.7%)60 (47.6%)79 (49.7%)0.2380.437
Hp δ value (‰)(interquartile range)6.25 (2.10–13.30)7.00 (2.10–14.50)19.00 (8.00–26.00)<0.001<0.001
Hp δ value ≥4‰86 (28.7%)31 (24.6%)130 (81.8%)<0.001<0.001

Abbreviations: AF, atrial fibrillation; SD, standard deviation; SBP, systolic blood pressure; WBC, white blood-cell count; NEU, neutrophil; LVEF, left ventricular ejection fraction; LAD, left atrium diameter; BMI, body mass index; hs-CRP, high sensitive C-reactive protein; HCY, homocysteine; Hp, Helicobacter pylori.

There were significant differences in the incidence of Hp-negative and Hp-IgG antibody negative (65.0% vs 69.8% vs 12.0%, P<0.001) and Hp-positive and Hp-IgG antibody positive (15.0% vs 18.3% vs 73.6%, P<0.001) among the groups (Figure 1). There were no significant differences in the incidence of Hp-negative and Hp-IgG antibody positive (7.7% vs 5.6% vs 6.3%, P=0.696) and Hp-positive and Hp-IgG antibody negative (18.1% vs 6.4% vs 16.5%, P=0.117) among the groups (Figure 1).
Figure 1

Comparison of Hp-positive/Hp-negative and Hp-IgG antibody-positive/Hp-IgG antibody-negative among the groups.

Abbreviations: Hp, Helicobacter pylori; AF, atrial fibrillation.

The Hp levels on admission were significantly higher in the long-standing AF group than in the short-standing AF group and control group (P<0.001, P<0.001, respectively; Table 1 and Figure 2).
Figure 2

Comparison of Hp levels among the groups (P<0.001).

Notes: The Hp levels on admission were significantly higher in the long-standing AF group than in the short-standing AF group and control group (P<0.001, P<0.001, respectively).

Abbreviations: Hp, Helicobacter pylori; AF, atrial fibrillation.

Comparison of Hp δ value, Hs-CRP, and LAD among five groups of AF

There was a significant difference in Hp δ value among the five groups (Table 2) of AF (P=0.034). Patients with permanent AF in Group 5 had a significantly higher Hp level than those in Group 1, 2, and 3 (P=0.005, 0.012, and 0.038, respectively); there was also a significant difference in hs-CRP value among the five groups (P=0.014). The median hs-CRP value of Group 5 was significantly higher than those of Group 1, 2, and 3 (P=0.000, 0.025, and 0.006, respectively). The mean LAD value in Group 5 was significantly higher than those in Group 1, 2, 3, and 4 (P=0.001, 0.010, 0.014, and 0.034, respectively) (Table 2).
Table 2

Comparing Hp δ value, hs-CRP, and LAD among five groups of AF

GroupTypes of AFnHp δ value (‰)hs-CRP (mg/L)LAD ± SD (mm)
1Initial AF346.35 (1.8–11.4)*4.30 (1.84–8.01)#35.9±3.80
2Paroxysmal AF585.25 (1.67–19.3)*5.58 (3.89–10.27)#37.1±4.64
3Persistent AF678.40 (2.50–19.0)*4.94 (2.50–11.56)#37.3±4.54
4Long persistent AF768.10 (2.43–30.4)5.83 (2.36–14.41)37.6±5.16
5Permanent AF5014.9 (4.13–31.0)*6.81 (5.25–16.68)#39.5±5.75

Notes:

Patients with permanent AF in Group 5 had a significantly higher Hp level than those in Group 1, 2, and 3.

The median hs-CRP value of Group 5 was significantly higher than those of Group 1, 2, and 3.

The mean LAD value in Group 5 was significantly higher than those in Group 1, 2, 3, and 4.

Abbreviations: Hp, Helicobacter pylori; hs-CRP, high sensitive C-reactive protein; LAD, left atrial diameter; AF, atrial fibrillation; SD, standard deviation.

Logistic regression analysis in patients with long-standing AF

The effects of variables in the presence of long-standing AF were determined by univariate and multivariate logistic regression analyses. In univariate analysis, we identified potential variables (age, HR, NEU, LAD, hs-CRP, Hp δ value, and HCY) and analyzed them by a multivariate logistic regression model. In multivariate analysis, Hp infection (odds ratio [OR] 13.172, 95% confidence interval [CI] 7.819–22.191, P<0.001) was still an independent predictor of long-standing AF as well as NEU (P<0.001), hs-CRP (P=0.002), and HCY (P<0.001) (Table 3).
Table 3

Predictors of presence of long-standing AF in logistic regression analysis

VariableUnivariate
Multivariate
OR (95% CI)POR (95% CI)P
Age1.040 (1.021–1.058)<0.0011.021 (0.997–1.045)0.090
Smoke0.928 (0.644–1.336)0.6870.956 (0.570–1.603)0.864
Hypertension1.055 (0.689–1.614)0.8061.117 (0.634–1.969)0.701
Dyslipidemia0.991 (0.682–1.440)0.9630.897 (0.538–1.497)0.687
Diabetes mellitus1.281 (0.868–1.892)0.2121.662 (0.352–7.845)0.521
Cerebral infarction1.327 (0.898–1.961)0.1560.592 (0.123–2.844)0.513
Hematencephalon0.890 (0.283–2.802)0.8432.805 (0.184–42.752)0.458
Family history of AF0.736 (0.269–2.017)0.5510.458 (0.042–5.020)0.523
Arteriosclerosis1.351 (0.917–1.991)0.1281.563 (0.943–2.592)0.083
HR >100 bpm2.492 (1.310–4.742)0.0051.927 (0.807–4.602)0.140
NEU >8×109/L5.730 (3.192–10.285)<0.0014.863 (2.338–10.113)<0.001
LAD >36 mm2.401 (1.656–3.481)<0.0012.469 (1.526–3.996)<0.001
Hs-CRP >5 mg/L2.069 (1.338–3.201)0.0012.458 (1.406–4.298)0.002
Hp δ value ≥4‰11.724 (7.435–18.487)<0.00113.172 (7.819–22.191)<0.001
HCY ≥15 μmol/L2.902 (1.993–4.226)<0.0013.203 (1.983–5.173)<0.001

Abbreviations: AF, atrial fibrillation; OR, odds ratio; CI, confidence interval; HR, heart rate; NEU, neutrophil; LAD, left atrial diameter; hs-CRP, high sensitive C-reactive protein; Hp, Helicobacter pylori; HCY, homocysteine.

The Hosmer–Lemeshow goodness of fit test showed chi-square 8.203, df 8, and P-value 0.414, and contingency table for Hosmer and Lemeshow test are shown in Table 4.
Table 4

Contingency table for Hosmer and Lemeshow test

Short-standing AF
Long-standing AF
Total
ObservedExpectedObservedExpected
5859.17520.82560
5757.40321.59759
5856.58512.41559
5255.12473.87659
5352.69366.30759
5048.439910.56159
4541.3171518.68360
3230.4812728.51959
1718.0944240.90659
46.6894845.31152

Abbreviation: AF, atrial fibrillation.

Receiver-operating characteristic curves analysis of Hp infection, LAD, NEU, hs-CRP, HCY, and multivariate variables for predicting long-standing AF

Hp δ value had a 66.7% sensitivity (95% CI 0.733–0.801), 78.4% specificity (95% CI 0.751–0.817), and the best critical value (14.75‰) in predicting long-standing AF (area under the curve [AUC] 0.774, Figure 3 and Table 5). LAD, NEU, hs-CRP, HCY, and multivariate variables for predicting longstanding AF are shown in Figure 3 and Table 5.
Figure 3

The ROC curves analysis of Hp infection, LAD, NEU, hs-CRP, HCY, and multivariate variables for predicting long-standing AF.

Abbreviations: ROC, receiver-operating characteristic; Hp, Helicobacter pylori; LAD, left atrial diameter; NEU, neutrophil; hs-CRP, high sensitive C-reactive protein; HCY, homocysteine; AF, atrial fibrillation.

Table 5

AUC, Se, and Sp

Test result variableArea under curve
Se (95% CI)Sp (95% CI)The best critical value
AUC (95% CI)P-value
Multivariate variables0.879 (0.847–0.912)<0.0010.767 (0.733–0.801)0.850 (0.821–0.879)0.359
Hp δ value ‰0.774 (0.729–0.820)<0.0010.667 (0.629–0.705)0.784 (0.751–0.817)14.75
NEU (109/L)0.669 (0.619–0.720)<0.0010.509 (0.468–0.550)0.765 (0.731–0.799)6.25
HCY (μmol/L)0.655 (0.608–0.702)<0.0010.541 (0.501–0.581)0.657 (0.619–0.695)12.52
hs-CRP (mg/L)0.694 (0.643–0.745)<0.0010.447 (0.407–0.487)0.934 (0.914–0.954)21.15
LAD (mm)0.662 (0.610–0.714)<0.0010.535 (0.495–0.575)0.796 (0.763–0.829)37.10

Abbreviations: AUC, area under curve; Se, sensitivity; Sp, specificity; CI, confidence interval; Hp, Helicobacter pylori; NEU, neutrophil; HCY, homocysteine; hs-CRP, high sensitive C-reactive protein; LAD, left atrial diameter.

Discussion

Research about AF began in the last century, but the mechanism of AF still has not been completely clarified to date. In recent years, with the continuous research of chronic Hp infection, the correlation between Hp and non-gastrointestinal diseases gradually entered people’s field of vision, especially the relationship between Hp and AF. However, the researchers have not reached an agreement. For example, a case-control study from Montenero in Italy showed that there was a strong correlation between chronic AF and Hp infection,6 but Lunetta et al did not find correlation between them in Italy population.9 Furthermore, most of these studies had no further classification for AF. Moreover, some studies only reported the relationship between Hp-IgG antibody and AF. There are great limitations to analyze the correlation between AF and plasma Hp-IgG antibody instead of Hp value, because the positive Hp-IgG antibody only shows that a patient has been infected with Hp previously and it does not reflect the situation in the patient with AF episode. Also, the sensitivity and specificity of Hp-IgG antibody for coronary heart disease are poor.10 Considering the exposure of Hp in different ways, this study conducted a subgroup analysis and categorized the individuals as Hp-negative (by both tests), Hp-positive (by both tests), previous Hp (Hp antibody-positive) but not current Hp (13C urea breath test-negative), and current Hp (by the breath test). It was found that Hp-positive (by both tests) had a higher rate of long-standing AF than other two groups (short-standing AF group and control group), which indicated that the continuing action of chronic inflammation played an important role in the persistence of AF. In our study, patients with AF were divided into five groups according to the classification of AF types in the 2012 European Society of Cardiology guidelines, and another classification was based on whether AF was persistent for more than 1 year. The study adopted 13C urea breath test to test situation of Hp infection, considering LAD, the level of hs-CRP, and other relevant clinical data, and further analyzed the correlation between Hp infection and AF. Our study found that there was a significant correlation between Hp δ value in the five groups. Patients with permanent AF in Group 5 had a higher level of Hp value than those in other groups. Patients with long-standing AF had a higher Hp value than those with short-standing AF. After adjusting for other important covariates in a multivariate regression model, Hp δ value ≥4‰ remained an independent predictor for long-standing AF.13,14 More and more evidence has shown that inflammation reaction has been closely related to AF since 1997. Inflammation and AF are inseparable and have interaction and reciprocal causation, although whether the inflammation is the inducement or the secondary outcome of AF has not been determined.13 CRP is recognized as one of the markers of inflammation. Some researchers have shown that CRP is one of the independent risk factors of AF, baseline CRP level can predict the risk of AF in the future, and CRP can reflect the degree of inflammation, which is closely related to the type and the duration of AF.14 Our study found that hs-CRP significantly increased in patients with long-standing AF, which was consistent with the results of previous research.13,14 The core part of the development of AF is atrial remodeling, which includes electrical remodeling, functional remodeling, and structural remodeling. Atrial electrical remodeling in patients with long-standing AF is chronic and irreversible, which results in substantial calcium influx, calcium overload, atrial systolic dysfunction, atrial passive extension, and atrial enlargement and further aggravates the functional remodeling and structural remodeling. The three different remodelings reinforce each other in a vicious cycle.13,14 The longer the duration of AF, the more obvious the atrial electrical remodeling and structural remodeling. Therefore, the LAD of patients with long-standing AF was significantly larger than those with short-standing AF in our study. Our study found that the Hp value was significantly increased in patients with long-standing AF. Since inflammation is closely related to AF and Hp infection can lead to chronic inflammation, thus, it is reasonable to believe that there may be some internal relations between Hp infection and AF. On one hand, if patients are infected with Hp, their bodies will produce H+/K+-ATP enzyme autoantibodies that bind to the H+/K+-ATP enzyme and then damage the atrial cell pump that makes the ion environment imbalanced and the depolarization delayed, which will trigger attack of AF.7 On the other hand, Hp will produce cytotoxin-associated protein A (CagA), which will stimulate gastric epithelial cells to produce interleukin-8, induce NEU infiltration, and result in a series of inflammatory reactions. The longer the Hp infection lasts, the greater the CagA toxicity will be sustained and the more severe the atrial muscle cells will be damaged.15 This long-term chronic persistent inflammation is likely to be the foundation of permanent and long-term persistent AF. The current study also found that Hp-IgG antibodies (which only shows that people were infected with Hp previously) had no correlation with the duration of AF, which also proved the important role of the continuing action of chronic inflammation in the development of AF. Although the study found Hp infection had a correlation with the duration of AF, it could not confirm that Hp infection induced the long-term AF. So there is the possibility of reverse causality – individuals with AF, particularly long-term AF, are more susceptible to Hp infection and/or higher values of Hp infection.

Limitations

However, the study had some limitations. On one hand, this study is a retrospective research and has a small sample size. At the other hand, it did not provide detailed information on socioeconomic status because education and income are generally associated with Hp infection and low socioeconomic status may also be associated with AF, although all the subjects came from the same community. Large prospective studies are expected to confirm what we found in the relationship between Hp infection and long-standing AF.
  15 in total

1.  Helicobacter pylori and atrial fibrillation: absence of correlations.

Authors:  Monica Lunetta; Giovanni Fazio; Valeria Avena; Egle Corrado; Sutera Loredana; Enrico Arnone; Giuseppina Novo; Salvatore Novo
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2009-01       Impact factor: 2.160

2.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.

Authors:  A John Camm; Gregory Y H Lip; Raffaele De Caterina; Irene Savelieva; Dan Atar; Stefan H Hohnloser; Gerhard Hindricks; Paulus Kirchhof
Journal:  Europace       Date:  2012-08-24       Impact factor: 5.214

3.  Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study).

Authors:  José Hermida; Faye L Lopez; Ramón Montes; Kunihiro Matsushita; Brad C Astor; Alvaro Alonso
Journal:  Am J Cardiol       Date:  2011-09-29       Impact factor: 2.778

4.  Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study.

Authors:  Katrin Schimke; Stephen A P Chubb; Wendy A Davis; Timothy M E Davis
Journal:  Atherosclerosis       Date:  2010-09       Impact factor: 5.162

5.  Recurrent atrial arrhythmia after minimally invasive pulmonary vein isolation for atrial fibrillation.

Authors:  Yaping Zeng; Yongqiang Cui; Yan Li; Xinpeng Liu; Chunlei Xu; Jie Han; Xu Meng
Journal:  Ann Thorac Surg       Date:  2010-08       Impact factor: 4.330

6.  Effect of volatile oil of amomum on expressions of platelet activating factor and mastocarcinoma-related peptide in the gastric membrane of chronic gastritis patients with helicobacter-pylori infection.

Authors:  Guo-dong Huang; Yuan-hua Huang; Mei-zhen Xiao; Dao-fu Huang; Juan Liu; Jia-bang Li
Journal:  Chin J Integr Med       Date:  2008-06-21       Impact factor: 1.978

7.  Permanent atrial fibrillation in patients without structural heart disease is not associated with signs of infection by Chlamydia pneumoniae and Helicobacter pylori.

Authors:  Pyotr Platonov; Rickard Ekesbo; Anders Hansson; Eva Andsberg; Carl J Meurling; Ingrid Nilsson; Asa Ljungh; Torkel Wadström; S Bertil Olsson
Journal:  Acta Cardiol       Date:  2008-08       Impact factor: 1.718

8.  Cytotoxin-associated gene-A bearing strains of Helicobacter pylori and atrial fibrillation due to ischemic origin: is there a link?

Authors:  Hala Mahfouz Badran; Magdi Elsayed Mahfouz
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-08

9.  Is Helicobacter pylori a cause of atrial fibrillation?

Authors:  Peter Andrew; Annibale Sandro Montenero
Journal:  Future Cardiol       Date:  2006-07

10.  Frequency of helicobacter pylori seropositivity and C-reactive protein increase in atrial fibrillation in patients undergoing coronary angiography.

Authors:  T Jared Bunch; John D Day; Jeffrey L Anderson; Benjamin D Horne; Joseph B Muhlestein; Brian G Crandall; J Peter Weiss; Donald L Lappe; Samuel J Asirvatham
Journal:  Am J Cardiol       Date:  2008-01-14       Impact factor: 2.778

View more
  7 in total

1.  Quantifying Risk Factors for Atrial Fibrillation: Retrospective Review of a Large Electronic Patient Database.

Authors:  Jaclyn Rivington; Patrick Twohig
Journal:  J Atr Fibrillation       Date:  2020-10-31

2.  Effect of proton pump inhibitor use on Helicobacter pylori positivity and atrial fibrillation.

Authors:  Kadri Atay; Omer Kaya
Journal:  Clin Interv Aging       Date:  2015-06-29       Impact factor: 4.458

3.  The Association between Arrhythmia and Helicobacter pylori Infection: A Meta-Analysis of Case-Control Studies.

Authors:  Jin Yan; Qiang She; Yifeng Zhang; Chang Cui; Guoxin Zhang
Journal:  Int J Environ Res Public Health       Date:  2016-11-16       Impact factor: 3.390

4.  Evaluation of Helicobacter pylori Infection in Patients with Chronic Hepatic Disease.

Authors:  Ju Huang; Jun Cui
Journal:  Chin Med J (Engl)       Date:  2017-01-20       Impact factor: 2.628

Review 5.  Association between atrial fibrillation and Helicobacter pylori.

Authors:  Cecilia Tetta; Amalia Ioanna Moula; Francesco Matteucci; Orlando Parise; Bart Maesen; Daniel Johnson; Mark La Meir; Sandro Gelsomino
Journal:  Clin Res Cardiol       Date:  2019-02-08       Impact factor: 5.460

Review 6.  Relationship Between Helicobacter pylori Infection and Arteriosclerosis.

Authors:  Yoshitaka Furuto; Mariko Kawamura; Jumpei Yamashita; Takahiro Yoshikawa; Akio Namikawa; Rei Isshiki; Hiroko Takahashi; Yuko Shibuya
Journal:  Int J Gen Med       Date:  2021-04-23

7.  Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori.

Authors:  Zi-Han Feng; Ling Fan; Jing Yang; Xing-Yue Huo; Yan Guo; Yi Zhang; Chun-Hui Lan
Journal:  BMC Microbiol       Date:  2019-08-05       Impact factor: 3.605

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.